Skip to main content

Biden Administration Launches Office for Long COVID Research

Medically reviewed by Drugs.com.

By Cara Murez HealthDay Reporter

TUESDAY, Aug. 1, 2023 -- As Americans continue to grapple with the effects of long COVID, the Biden administration on Monday announced the creation of a new office focused on research about the condition that will be part of the U.S. Department of Health and Human Services.

The Office of Long COVID Research and Practice will lead the U.S. response to long COVID, which incudes trials that have already been launched, the HHS said in an agency news release.

“As our nation continues to make strides in combating COVID-19, it is crucial that we address the impact of long COVID and provide resources to those in need,” said HHS Secretary Xavier Becerra. “Last year, President Biden called on HHS to coordinate the response to long COVID. The official establishment of the Long COVID Coordinating office and the launch of the RECOVER clinical trials solidifies this issue as an ongoing priority.”

The $1.15 billion RECOVER research program is meant to better understand, treat and prevent long COVID; as many as 23 million Americans have developed the condition, according to HHS estimates.

Research has identified 12 possible symptoms of long COVID, including worsening of health after mental or physical activity, fatigue, brain fog and dizziness, changes in taste or smell, thirst and changes in sexual desire or capacity. It can also include gastrointestinal symptoms, heart palpitations, chronic cough, chest pain and abnormal movements.

These are among more than 200 symptoms that have been associated with long COVID.

“The Office of Long COVID Research and Practice will enhance efforts being undertaken across the U.S. government to improve the lives of those who continue to experience the long-term impacts of the worst public health crisis in a century,” said HHS Assistant Secretary of Health Adm. Dr. Rachel Levine, who will lead the new research effort. “Bringing together the resources and expertise of federal, state and local partners, patients, providers, researchers and the business sector to answer the American peoples' most urgent calls to action.”

Sources

  • Department of Health and Human Services, news release, July 31, 2023

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Further Support and Information on COVID-19

Read this next

Extended Course of Paxlovid Adds No Benefit for Those With Long COVID

FRIDAY, June 7, 2024 -- An extended course of the antiviral drug Paxlovid won’t ease a person’s Long COVID symptoms, a new study finds. People who took Paxlovid for...

Texas Rancher Developed Anthrax From Butchered Lamb Meat

FRIDAY, June 7, 2024 -- Anthrax disease in humans is rare and when it does occur, it's usually during hot, dry summers. That's why the case of a Texas rancher who developed...

Could Brain 'Overgrowth' Contribute to Autism?

FRIDAY, June 7, 2024 -- Severe forms of autism could be linked to overgrowth of the brain’s outer layer that starts while a baby is in the womb, a new study finds. Toddlers...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.